Single Oral Administration of Captopril may not bring an Improvement in Screening of Primary Aldosteronism

H. Muratani Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

I. Abe Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

Y. Tomita Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

M. Ueno Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

S. Takishita Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

N. Kawazoe Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

T. Tsuchihashi Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

T. Kawasaki Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan; Institute of Health Science Kyushu University, Kasuga, 815, Japan

M. Fujishima Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, 812, Japan

show all

Abstract

Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured in 19 cases with primary aldosteronism (PA) and 72 with essential hypertension (EHT) to differentiate the two disorders in the following conditions: 1) after overnight recumbency (basal state) and 2) after oral administration of captopril. Screening criteria were determined in order to pick up all of PA patients as positive. After the captopril administration, the specificity of a criterion based on the combination of PAC and PAC/PRA ratio was 93 % and positive predictive value 79 %. This criterion was superior to other conventional screening methods. However, higher specificity (97 %) and positive predictive value (90 %) were obtained from a combination criterion based on the basal PAC and PAC/PRA ratio. The single oral administration of captopril may not bring an improvement in the screening of PA.

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Single Oral Administration of Captopril may not bring an Improvement in Screening of Primary Aldosteronism

Information for

Open access

Opportunities

Help and information

Single Oral Administration of Captopril may not bring an Improvement in Screening of Primary Aldosteronism

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature